Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (23)

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial

    European Journal of Clinical Investigation, Vol. 53, Núm. 1

  4. Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity

    Revista Clinica Espanola, Vol. 223, Núm. 3, pp. 134-143

  5. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  6. High cobalamin levels as a five-year risk predictor for developing hematological cancer

    Minerva medica, Vol. 114, Núm. 1, pp. 22-28

  7. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

2022

  1. Cancer and elderly: Two incompatible concepts for intensive care?

    Revista Espanola de Geriatria y Gerontologia

  2. Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

    Frontiers in Endocrinology, Vol. 13

  3. Esophageal Papillomas as an Endoscopic Finding

    Eurasian Journal of Medicine

  4. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  5. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

  6. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

    Journal of the American Geriatrics Society

2021

  1. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  2. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  3. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

  4. The nutritional status of the elderly patient infected with COVID-19: the forgotten risk factor?

    Current Medical Research and Opinion, Vol. 37, Núm. 4, pp. 549-554

2020

  1. Black esophagus and diabetes: a close relationship

    Cardiovascular Endocrinology and Metabolism, Vol. 10, Núm. 1, pp. 59-61

  2. Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events

    Internal and Emergency Medicine, Vol. 15, Núm. 8, pp. 1533-1544

  3. Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination

    Revista Clinica Espanola, Vol. 220, Núm. 8, pp. 511-517